C
Description
Contract research and development organisation specialising in solid state and formulation of small molecules. It covers polymorph, salt and cocrystal screening, single-crystal structure determination, solid-state NMR, crystallisation process development, preformulation, oral solid dosage forms and bioavailability enhancement. Founded in 2010, it reports around 250 employees and a quality system compliant with NMPA, FDA and EMA.